Ambar Kusuma Astuti

Ambar Kusuma Astuti

Auto-generated profile, based on publicly available information

Ambar Kusuma Astuti

Universitas Indonesia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2025 in Science Progress
Verified
Journal Article
Open access
AAAmbar Kusuma Astuti
Ambar Kusuma Astuti
AYAndi Yasmon
Andi Yasmon
MLMelva Louisa
Melva Louisa
PWPuspita Eka Wuyung
Puspita Eka Wuyung
JWJumpei Washio
Jumpei Washio
YWYuniardini Wimardhani
Yuniardini Wimardhani
Objective: The balance of oral microbiota is important in oral disease prevention and treatment. Oral microbiomes play an essential role in oral diseases through anti-inflammatory effects and restoring dysbiosis. Lactococcus lactis subspecies lactis strains Y-PDH01-07 (LL01-07) were identified from dadih , a traditional Indonesian fermented milk. Previous research had shown that dadih can reduce colon inflammation. However, the characteristics of LL01-07 as an oral probiotic have not been explored. The objective of this research is to characterize and functionally assess the potential of LL01-07 as an oral probiotic. Methods: Strains were identified using phenotypic features, PCR, and sequencing, and their biosafety status was evaluated. The oral probiotic characterization of LL01-07 consisted of carbohydrate fermentation ability, antimicrobial activity, auto-aggregation, hydrophobicity, and acid resistance. An in vivo experiment was conducted to evaluate its anti-inflammatory effect on the oral mucosal wound model with unpaired t-test to evaluate the group's significance. Results: Genotypic results confirmed that all isolates were Lactococcus lactis subsp. lactis , and biosafety assessment showed no inhibition zone in antibiotic resistance test and no hemolytic activity. LL05 had the highest % auto aggregation: 15.0 ± 1.7% at 33 h and 54.2 ± 4.8% at 22 h. LL05 had the best acid resistance test (75.2% survival after 4 h of acid exposure). The lesion severity score did not improve in the treatment group, but body weight increased. Conclusions: LL 01-07 was safe to administer to oral cavity but showed less oral probiotic potential. The in vivo study showed that the treatment group had a lower wound healing effect score but a higher average body weight.